| Primary |
| Non-small Cell Lung Cancer |
28.2% |
| Ovarian Cancer |
14.6% |
| Breast Cancer |
7.9% |
| Lung Neoplasm Malignant |
5.8% |
| Product Used For Unknown Indication |
5.2% |
| Premedication |
4.9% |
| Small Cell Lung Cancer Stage Unspecified |
3.5% |
| Prophylaxis |
3.4% |
| Pain |
2.8% |
| Nausea |
2.6% |
| Ovarian Cancer Recurrent |
2.5% |
| Hypertension |
2.5% |
| Chemotherapy |
2.3% |
| Medulloblastoma |
2.3% |
| Lung Adenocarcinoma |
2.1% |
| Head And Neck Cancer |
2.0% |
| Breast Cancer Metastatic |
2.0% |
| Neoplasm Malignant |
2.0% |
| Rhabdomyosarcoma |
1.8% |
| Retinoblastoma |
1.6% |
|
| Vomiting |
18.3% |
| White Blood Cell Count Decreased |
9.2% |
| Neutropenia |
8.4% |
| Thrombocytopenia |
8.4% |
| Neutrophil Count Decreased |
6.4% |
| Pyrexia |
4.7% |
| Dyspnoea |
4.1% |
| Sepsis |
4.0% |
| Febrile Neutropenia |
3.9% |
| Nausea |
3.9% |
| Pneumonia |
3.6% |
| Hypersensitivity |
3.0% |
| Syncope |
3.0% |
| Pruritus |
2.9% |
| Renal Failure Chronic |
2.9% |
| Pancytopenia |
2.7% |
| Pulmonary Embolism |
2.7% |
| Tachycardia |
2.7% |
| Urinary Tract Infection |
2.7% |
| Weight Decreased |
2.5% |
|
| Secondary |
| Non-small Cell Lung Cancer |
28.4% |
| Drug Use For Unknown Indication |
14.3% |
| Breast Cancer |
13.1% |
| Ovarian Cancer |
5.9% |
| Product Used For Unknown Indication |
4.1% |
| Prophylaxis |
3.9% |
| Hypertension |
3.5% |
| Pain |
3.1% |
| Premedication |
2.9% |
| Lung Neoplasm Malignant |
2.7% |
| Ovarian Epithelial Cancer |
2.7% |
| Head And Neck Cancer |
2.5% |
| Nausea |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.1% |
| Breast Cancer Metastatic |
1.7% |
| Constipation |
1.4% |
| Lung Adenocarcinoma |
1.4% |
| Hodgkin's Disease |
1.3% |
| Neuroblastoma |
1.3% |
| Non-hodgkin's Lymphoma |
1.3% |
|
| Vomiting |
13.8% |
| Thrombocytopenia |
13.2% |
| Pyrexia |
6.5% |
| White Blood Cell Count Decreased |
6.0% |
| Pneumonia |
5.6% |
| Sepsis |
5.4% |
| Neutropenia |
5.2% |
| Febrile Neutropenia |
5.2% |
| Pulmonary Embolism |
4.4% |
| Anaemia |
4.1% |
| Respiratory Failure |
3.8% |
| Dehydration |
3.6% |
| Death |
3.4% |
| Dyspnoea |
3.2% |
| Syncope |
3.2% |
| Renal Failure Acute |
3.1% |
| Pancytopenia |
2.9% |
| Weight Decreased |
2.8% |
| Renal Failure |
2.5% |
| Diarrhoea |
2.3% |
|
| Concomitant |
| Non-small Cell Lung Cancer |
14.5% |
| Drug Use For Unknown Indication |
10.9% |
| Prophylaxis |
10.8% |
| Product Used For Unknown Indication |
9.1% |
| Breast Cancer |
7.7% |
| Ovarian Cancer |
5.7% |
| Chemotherapy |
5.2% |
| Breast Cancer Metastatic |
5.0% |
| Lung Neoplasm Malignant |
4.9% |
| Lung Adenocarcinoma |
4.5% |
| Premedication |
3.5% |
| Metastases To Bone |
2.7% |
| Lung Adenocarcinoma Metastatic |
2.6% |
| Pain |
2.3% |
| Hypertension |
2.1% |
| Cough |
1.9% |
| Nausea |
1.8% |
| Neoplasm Malignant |
1.8% |
| Dehydration |
1.7% |
| Constipation |
1.5% |
|
| Thrombocytopenia |
11.2% |
| Vomiting |
9.5% |
| Death |
7.9% |
| White Blood Cell Count Decreased |
7.8% |
| Weight Decreased |
6.4% |
| Rash |
5.5% |
| Disease Progression |
5.4% |
| Pyrexia |
5.0% |
| Pneumonia |
4.5% |
| Sepsis |
4.3% |
| Pulmonary Embolism |
4.1% |
| Malignant Neoplasm Progression |
3.9% |
| Wound Treatment |
3.6% |
| Pleural Effusion |
3.3% |
| Dyspnoea |
3.2% |
| Interstitial Lung Disease |
3.0% |
| Platelet Count Decreased |
2.9% |
| Febrile Neutropenia |
2.8% |
| Nausea |
2.8% |
| Neutropenia |
2.8% |
|
| Interacting |
| Transitional Cell Carcinoma |
14.3% |
| Bladder Cancer |
11.8% |
| Breast Cancer Metastatic |
10.9% |
| Breast Cancer |
7.6% |
| Product Used For Unknown Indication |
6.7% |
| Retinoblastoma |
6.7% |
| Chemotherapy |
4.2% |
| Malignant Hydatidiform Mole |
4.2% |
| Cervix Carcinoma |
3.4% |
| Convulsion |
3.4% |
| Hypothyroidism |
3.4% |
| Lung Neoplasm Malignant |
3.4% |
| Post-traumatic Epilepsy |
3.4% |
| General Anaesthesia |
2.5% |
| Lung Adenocarcinoma Stage Iv |
2.5% |
| Metastasis |
2.5% |
| Neoplasm Malignant |
2.5% |
| Pain |
2.5% |
| Prophylaxis |
2.5% |
| Anticoagulant Therapy |
1.7% |
|
| Dizziness |
12.9% |
| Drug Interaction |
9.7% |
| Ocular Vascular Disorder |
6.5% |
| Pancreatitis |
6.5% |
| Respiratory Failure |
6.5% |
| Swelling |
6.5% |
| Thrombocytopenia |
6.5% |
| Weight Decreased |
6.5% |
| Convulsion |
3.2% |
| Febrile Neutropenia |
3.2% |
| Flank Pain |
3.2% |
| Inappropriate Antidiuretic Hormone Secretion |
3.2% |
| Infusion Site Extravasation |
3.2% |
| Myelodysplastic Syndrome |
3.2% |
| Nervousness |
3.2% |
| Osteonecrosis |
3.2% |
| Personality Disorder |
3.2% |
| Pleural Effusion |
3.2% |
| Pneumonitis |
3.2% |
| Rash |
3.2% |
|
